cakrawala
EGFR Tyrosine Kinase Inhibitor therapy in progressive lung cancer patient
Tyrosine kinase inhibitor (TKI) has been widely used as a cancer therapy for patients who have EGFR mutations. However, patients who have EGFR mutations only
13 Desember 2019
Tidak ada komentar
